Research programme: crotamine - Celtic Biotech Iowa
Latest Information Update: 08 Oct 2015
At a glance
- Originator Instituto Butanan
- Developer Celtic Biotech Iowa
- Class Imaging agents; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Small molecules
- Mechanism of Action Ionising radiation emitters; Positron-emission tomography enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Lung cancer